Gary Gershony

Gary Gershony has a diverse work experience in the medical field. Gary is currently the Founding General Partner at BayMed Venture Partners since July 2020. Additionally, they serve as the Director on the Board of Directors at Deep Blue Medical Advances, Inc. since June 2022, Crystalline Medical since April 2021, and RAM Medical Innovations since January 2020. Gary is also a member of the Scientific Advisory Board at AtaCor Medical, Inc. since January 2020 and serves on the Board of Directors at VALFIX medical since October 2019.

Gary has been an Angel Investor at Band of Angels since March 2019 and Life Science Angels since 2018.

Before their current positions, Gary worked at John Muir Health for nearly a decade. Gary held the role of Director of Cardiovascular Research, Education, and Technology, where they oversaw all cardiovascular education and clinical studies and evaluated new technologies for the organization. Gary was also a practicing board-certified interventional cardiologist and the founder of the TAVR program at John Muir Health Cardiovascular Institute. Gary'stenure at John Muir Health lasted from 2012 until December 2021.

Prior to John Muir Health, Gary held the role of Founder & Chief Medical Officer at AngioScore, which is now part of Philips/Volcano, from 2003 to 2014.

Gary Gershony attended the Emory University School of Medicine, where they completed the Interventional Cardiology Fellowship Program. Gary then pursued their Doctor of Medicine (MD) degree at the University of Toronto, specializing in Medicine. Following this, they attended the Stanford University Graduate School of Business, participating in the FANFE - Executive Program. The specific start and end years for each of their educational experiences were not provided.